Melanoma Clinical Trials in Chicago

Showing 141-158 of 158 trials

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

NCT00004153

RATIONALE: Diagnostic procedures may improve the ability to detect the presence or recurrence of disease. PURPOSE: Diagnostic trial to detect melanoma markers in the lymph nodes or peripheral blood of patients who have melanoma.

Melanoma (Skin)

University of Chicago106 participantsStarted Jun 1998

Chicago, Illinois, United States

COMPLETEDPHASE22.2 miles

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

NCT00026520

RATIONALE: Interferon alfa may interfere with the growth of cancer cells and slow the growth of the tumor. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. Combining interferon alfa with thalidomide may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining interferon alfa with thalidomide in treating patients who have stage IV melanoma.

Melanoma (Skin)

SWOG Cancer Research NetworkStarted Nov 2001

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +91 more locations

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Melanoma Trials in Other Cities

Tipifarnib in Treating Patients With Metastatic Malignant Melanoma

Study of CP-675,206 in Refractory Melanoma

CP-675,206 In Patients With Advanced Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Study of XL281 in Adults With Solid Tumors

A Study of Volociximab in Metastatic Melanoma

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Other Conditions in Chicago